Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

Alicia Morgans, MD, on Treatment Options for Metastatic Castration-Sensitive Prostate Cancer

Advances in upfront hormonal and chemohormonal therapy have driven a dramatic shift in treatment paradigms for metastatic castration-sensitive prostate cancer... Read More

New Focus on ADT in Prostate Cancer Guideline

For the first time in its long and storied history, hormonal therapy for advanced prostate cancer has received broad and... Read More

Consider Genetic Testing in All Metastatic Prostate Cancers

All men with metastatic prostate cancer should consider testing for germline mutations, as should men with a family history of... Read More

Stepped-Up Surveillance Warranted in Men With Strong Family History of Prostate Cancer

It is well-established that men with a family history of prostate cancer have a higher likelihood of developing the disease... Read More

Clinical Challenges: Nuclear Medicine and Biochemically Recurrent Prostate Cancer

With the advent of fluciclovine and PSMA, nuclear medicine has carved out a key role in the visualization of prostate... Read More

Prostate Cancer Mortality: Groups Squabble Over ACS Forecast

Every January since 1951, the American Cancer Society (ACS) has published its report card on cancer, “Cancer Facts & Figures.” The... Read More

Prostate Cancer and Race

How much does infamous Tuskegee Experiment still loom over care for African Americans? Over the years, as a staff medical... Read More

High Anxiety with Active Surveillance in Prostate Cancer?

High anxiety with Active Surveillance in prostate cancer? not really. In my case, the first week after diagnosis was bad,... Read More

Novel Assay Can Guide Therapy in Advanced Prostate Cancer

A biochemical assay that can identify metastatic castration-resistant prostate cancer (mCRPC) patients best treated with either androgen receptor signaling (ARS)... Read More

Prostate Cancer Subtype that Responds to Immunotherapy Identified

Investigators from the U.S. and U.K. have identified a subtype of prostate cancer that may respond to immune checkpoint inhibitor... Read More

1 2